Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
Recruiting
- Conditions
- Atopic Dermatitis
- Registration Number
- NCT05098821
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Inclusion Criteria:<br><br> - Age 18 and above<br><br> - Diagnosis of atopic dermatitis for =1 year<br><br> - Inadequate response to treatment with topical medications<br><br> - Confirmed dupilumab treatment<br><br>Exclusion Criteria:<br><br> - Age below 18<br><br> - Known or suspected allergy or reaction to any component of the dupilumab formulation<br><br> - Known active allergic or irritant contact dermatitis that is likely to interfere<br> with the assessment of the severity of AD<br><br> - Severe conjunctivitis or blepharitis
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational [Patient Registry]
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of T-cell inflammatory markers
- Secondary Outcome Measures
Name Time Method Different T-cell pattern with dupilumab therapy;Assign recognition patterns to clinical symptoms;Connection of molecular profile and phenotype